Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)
Phase 3
Completed
- Conditions
- Dry Eye Syndromes
- Registration Number
- NCT00548301
- Lead Sponsor
- Sirion Therapeutics, Inc.
- Brief Summary
The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Diagnosis of moderate to severe dry eye syndrome with or without Sjogren's syndrome or other autoimmune disease
Exclusion Criteria
- Intraocular or refractive surgery in the study eye within 3 months prior to study start
- Unwilling to discontinue use of contact lenses during the run-in and duration of the study
- Pregnancy or lactation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Eye Center Northeast
🇺🇸Bangor, Maine, United States